Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

kinase inhibitor TQB3912

An orally bioavailable small molecule protein kinase inhibitor, with potential antineoplastic activity. Upon oral administration, kinase inhibitor TQB3912 may target, bind to and inhibit the activity of a protein kinase that plays an important role in tumor cell survival, proliferation, migration, and differentiation.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	protein kinase inhibitor TQB3912
Code name:	TQB 3912 TQB-3912 TQB3912

kinase inhibitor TQB3912

Search NCI's Drug Dictionary